Skip to main content

Advertisement

SpringerLink
Log in

Membranous nephropathy: not just a disease for adults

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Membranous nephropathy (MN) is an immune complex-mediated cause of the nephrotic syndrome that can occur in all age groups, from infants to the elderly. While systemic disorders such as hepatitis B infection or lupus may more frequently cause secondary MN in the younger population, primary or “idiopathic” MN has generally been considered a disease of adults. Recent progress in our understanding of primary disease was recently made when the target antigen in primary MN was identified as the M-type phospholipase A2 receptor (PLA2R). Circulating anti-PLA2R antibodies may serve both as a diagnostic tool for distinguishing primary from secondary disease and as a biomarker for monitoring the immunologic activity of this organ-specific autoimmune disease during treatment. Whereas definitive therapy for secondary forms of MN should be targeted at the underlying cause, immunosuppressive therapy is often necessary for primary disease. Alkylating agents in combination with corticosteroids, as well as calcineurin inhibitors (± steroids), are first line agents due to randomized controlled trials in an adult population with relatively long durations of follow-up. However, rituximab, mycophenolate and adrenocorticotropic hormone have shown promise in smaller and/or observational studies. The optimal therapy for children and adolescents with MN is less well defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299–1302

    Article  CAS  PubMed  Google Scholar 

  2. Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25:1419–1428

    Article  PubMed Central  PubMed  Google Scholar 

  3. Waldman M, Austin HA (2012) Treatment of idiopathic membranous nephropathy. J Am Soc Nephrol 23:1617–1630

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD (2013) Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 26:709–715

    Article  CAS  PubMed  Google Scholar 

  5. Ponticelli C (2007) Membranous nephropathy. J Nephrol 20:268–287

    CAS  PubMed  Google Scholar 

  6. Forland M, Spargo BH (1969) Clinicopathological correlations in idiopathic nephrotic syndrome with membranous nephropathy. Nephron 6:498–525

    Article  CAS  PubMed  Google Scholar 

  7. Latham P, Poucell S, Koresaar A, Arbus G, Baumal R (1982) Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study. J Pediatr 101:682–685

    Article  CAS  PubMed  Google Scholar 

  8. Rodriguez EF, Cosio FG, Nasr SH, Sethi S, Fidler ME, Stegall MD, Grande JP, Fervenza FC, Cornell LD (2012) The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 12:1029–1038

    Article  CAS  PubMed  Google Scholar 

  9. Huang CC, Lehman A, Albawardi A, Satoskar A, Brodsky S, Nadasdy G, Hebert L, Rovin B, Nadasdy T (2013) IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 26:799–805

    Article  CAS  PubMed  Google Scholar 

  10. Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, Iijima K, Yoshikawa N (2006) Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol 1:723–729

    Article  PubMed  Google Scholar 

  11. Mubarak M, Kazi JI, Lanewala A, Hashmi S, Akhter F (2012) Pathology of idiopathic nephrotic syndrome in children: are the adolescents different from young children? Nephrol Dial Transplant 27:722–726

    Article  PubMed  Google Scholar 

  12. Hogg RJ, Silva FG, Berry PL, Wenz JE (1993) Glomerular lesions in adolescents with gross hematuria or the nephrotic syndrome. Report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 7:27–31

    Article  CAS  PubMed  Google Scholar 

  13. Moxey-Mims MM, Stapleton FB, Feld LG (1994) Applying decision analysis to management of adolescent idiopathic nephrotic syndrome. Pediatr Nephrol 8:660–664

    Article  CAS  PubMed  Google Scholar 

  14. Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H (2007) Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 8:11

    Article  PubMed Central  PubMed  Google Scholar 

  15. McGrogan A, Franssen CF, de Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430

    Article  PubMed  Google Scholar 

  16. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H, Research Group on Progressive Renal Diseases in J (2004) Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65:1400–1407

    Article  PubMed  Google Scholar 

  17. du Buf-Vereijken PW, Branten AJ, Wetzels JF (2005) Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis 46:1012–1029

    Article  PubMed  Google Scholar 

  18. Cameron JS (1990) Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 4:193–198

    Article  CAS  PubMed  Google Scholar 

  19. US Renal Data System (2012) U.S. Renal Data System, USRDS 2012 Annual data report: Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases, Bethesda. Available at: http://www.usrds.org/archive.aspx

  20. Tsukahara H, Takahashi Y, Yoshimoto M, Hayashi S, Fujisawa S, Suehiro F, Akaishi K, Nomura Y, Morikawa K, Sudo M (1993) Clinical course and outcome of idiopathic membranous nephropathy in Japanese children. Pediatr Nephrol 7:387–391

    Article  CAS  PubMed  Google Scholar 

  21. Wang X, Huang JP, Zhu BZ, Yao Y, Xiao HJ (2011) Clinicopathological feature and treatment of idiopathic membranous nephropathy in children. Zhonghua Er Ke Za Zhi 49:311–315

    PubMed  Google Scholar 

  22. Kerlin BA, Ayoob R, Smoyer WE (2012) Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7:513–520

    Google Scholar 

  23. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL (1959) Production of nephrotic syndrome in rats by Freund’s adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 100:660–664

    Article  CAS  PubMed  Google Scholar 

  24. Cybulsky AV, Quigg RJ, Salant DJ (2005) Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 289:F660–671

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Van Damme BJ, Fleuren GJ, Bakker WW, Vernier RL, Hoedemaeker PJ (1978) Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 38:502–510

    PubMed  Google Scholar 

  26. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM (1978) Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62:1275–1287

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Kerjaschki D, Farquhar MG (1982) The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 79:5557–5561

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Farquhar MG, Saito A, Kerjaschki D, Orlando RA (1995) The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J Am Soc Nephrol 6:35–47

    CAS  PubMed  Google Scholar 

  29. Kerjaschki D, Miettinen A, Farquhar MG (1987) Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. J Exp Med 166:109–128

    Article  CAS  PubMed  Google Scholar 

  30. Salant DJ, Quigg RJ, Cybulsky AV (1989) Heymann nephritis: mechanisms of renal injury. Kidney Int 35:976–984

    Article  CAS  PubMed  Google Scholar 

  31. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschenes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053–2060

    Article  PubMed  Google Scholar 

  32. Ronco P, Debiec H (2007) Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol 29:445–458

    Article  CAS  PubMed  Google Scholar 

  33. Debiec H, Nauta J, Coulet F, van der Burg M, Guigonis V, Schurmans T, de Heer E, Soubrier F, Janssen F, Ronco P (2004) Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 364:1252–1259

    Article  CAS  PubMed  Google Scholar 

  34. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6:1286–1291

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA (2011) An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26:2526–2532

    Article  CAS  PubMed  Google Scholar 

  37. Debiec H, Ronco P (2011) PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 364:689–690

    Article  CAS  PubMed  Google Scholar 

  38. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22:1137–1143

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS (2013) Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One 8:e62151

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ (2011) Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22:1543–1550

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1735–1743

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W (2013) Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421C:213–218

    Article  Google Scholar 

  43. Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travels and new roads ahead. Kidney Int 77:765–770

    Article  CAS  PubMed  Google Scholar 

  44. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, Poulton K, McWilliam L, Short CD, Venning M, Brenchley PE (2013) Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83:940–948

    Article  CAS  PubMed  Google Scholar 

  45. Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA (2012) Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 82:797–804

    Article  CAS  PubMed  Google Scholar 

  46. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R (2011) Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364:616–626

    Article  CAS  PubMed  Google Scholar 

  47. Coenen MJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B, Boland-Augé A, Groothuismink JM, Bockenhauer D, Powis SH, Mathieson PW, Brenchley PE, Kleta R, Wetzels JF, Ronco P (2013) Phospholipase A2 Receptor (PLA2R1) Sequence Variants in Idiopathic Membranous Nephropathy. J Am Soc Nephrol 24:677–683

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Lv J, Hou W, Zhou X, Liu G, Zhou F, Zhao N, Hou P, Zhao M, Zhang H (2013) Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 24:1323–1329

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Cossey LN, Walker PD, Larsen CP (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307–2311

    Article  PubMed  Google Scholar 

  50. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, Bruno F, Radice A, Furci L, Argentiero L, Carnevali ML, Messa P, Scolari F, Sinico RA, Gesualdo L, Fervenza FC, Allegri L, Ravani P, Ghiggeri GM (2012) Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7:1394–1400

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschenes G, Remuzzi G, Ulinski T, Ronco P (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101–2110

    Article  CAS  PubMed  Google Scholar 

  52. Zeng CH, Chen HM, Wang RS, Chen Y, Zhang SH, Liu L, Li LS, Liu ZH (2008) Etiology and clinical characteristics of membranous nephropathy in Chinese patients. Am J Kidney Dis 52:691–698

    Article  PubMed  Google Scholar 

  53. Kleinknecht C, Levy M, Gagnadoux MF, Habib R (1979) Membranous glomerulonephritis with extra-renal disorders in children. Medicine (Baltimore) 58:219–228

    Article  CAS  Google Scholar 

  54. Fang ZL, Harrison TJ, Yang JY, Chen QY, Wang XY, Mo JJ (2012) Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization. J Med Virol 84:878–884

    Article  PubMed  Google Scholar 

  55. Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK (2011) Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 128:e600–604

    PubMed  Google Scholar 

  56. Xu H, Sun L, Zhou LJ, Fang LJ, Sheng FY, Guo YQ (2003) The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis. Pediatr Nephrol 18:1216–1219

    Article  PubMed  Google Scholar 

  57. Cameron JS (1993) Lupus and lupus nephritis in children. Adv Nephrol Necker Hosp 22:59–119

    CAS  PubMed  Google Scholar 

  58. Lau KK, Jones DP, Hastings MC, Gaber LW, Ault BH (2006) Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children. Pediatr Nephrol 21:655–662

    Article  PubMed  Google Scholar 

  59. Wong SN, Chan WK, Hui J, Chim S, Lee TL, Lee KP, Leung LC, Tse NK, Yuen SF (2009) Membranous lupus nephritis in Chinese children–a case series and review of the literature. Pediatr Nephrol 24:1989–1996

    Article  PubMed  Google Scholar 

  60. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274

    Article  Google Scholar 

  61. Valentini RP, Mattoo TK, Kapur G, Imam A (2009) Membranous glomerulonephritis: treatment response and outcome in children. Pediatr Nephrol 24:301–308

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Renal Section, Boston University School of Medicine, 650 Albany Street Boston, Boston, MA, 02118, USA

    Rivka Ayalon & Laurence H. Beck Jr.

Authors
  1. Rivka Ayalon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurence H. Beck Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence H. Beck Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayalon, R., Beck, L.H. Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30, 31–39 (2015). https://doi.org/10.1007/s00467-013-2717-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-013-2717-z

Keywords

Search

Navigation